Analyst Alethia Young works at CANTOR FITZGERALD and is focused on Healthcare, Basic Materials sectors with 640 price targets and ratings documented since 2012 spanning on 39 stocks. Previously, Alethia Young worked at CREDIT SUISSE, DEUTSCHE BANK. Analyst's average stock valuation to be materialised ratio is 57.08% with an average time for price targets to be met of 330.54 days.
Most recent stock forecast was given on NEXI, at 16-Nov-2022.
Alethia Young best performing recommendations are on CLVS (CLOVIS ONCOLOGY, INC).
The best stock recommendation documented was for BIIB (BIOGEN INC) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
4
4 years 11 months 29 days ago
4/4 (100%)
$-2.13 (-24.58%)
106
Buy
5
$2.11 (73.01%)
6
5 years 1 months 26 days ago
0/3 (0%)
$3.56 (62.56%)
Hold
4
$1.11 (38.41%)
5
5 years 4 months 26 days ago
7/9 (77.78%)
$1.9 (34.61%)
48
Buy
7
$4.11 (142.21%)
5
5 years 5 months 27 days ago
4/10 (40%)
$6.15 (78.41%)
235
Buy
6 years 6 months 30 days ago
0/1 (0%)
$-0.48 (-32.43%)
